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Abstract
Background—Chronic obstructive pulmonary disease (COPD) imposes a large public health 
burden internationally and in the United States. The objective of this study was to examine trends 
in mortality from COPD among US adults from 1968 to 2011.
Methods—Data from the National Vital Statistics System from 1968 to 2011 for adults aged ≥25 
years were accessed, and trends in mortality rates were examined with Joinpoint analysis.
Results—Among all adults, age-adjusted mortality rose from 29.4 per 100,000 population in 
1968 to 67.0 per 100,000 population in 1999 and then declined to 63.7 per 100,000 population in 
2011 (annual percentage change [APC] 2000–2011: −0.2%, 95% confidence interval [CI]: −0.6, 
0.2). The age-adjusted mortality among men peaked in 1999 and then declined (APC 1999–2011: 
−1.1%, 95% CI: −1.4, −0.7), whereas the age-adjusted mortality rate among women peaked in 
2008 and subsequently increased slowly (APC 2000–2011: 0.4%, 95% CI: 0.0, 0.9). Despite a 
narrowing of the gender gap, mortality rates in men continued to exceed those in women. 
Evidence of a decline in the APC was noted for African American (1999–2011: −1.5%, 95% CI: 
−2.1, −1.0) and white men (1999–2011: −0.9%, 95% CI: −1.3, −0.6), adults aged 55–64 years 
(1989–2011: −1.0%, 95% CI: −1.2, −0.8), and adults aged 65–74 years (1999–2011: −1.2%, 95% 
CI: −1.6, −0.9).
Conclusions—In the United States, the mortality rate from COPD has declined since 1999 in 
men and some age groups but appears to be still rising in women, albeit at a reduced pace.
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Chronic obstructive pulmonary disease (COPD) is a major source of morbidity and mortality 
internationally.1,2 In 1997, COPD was predicted to become the third leading cause of global 
death by 2020,3 but a subsequent analysis found that COPD had become the third leading 
cause of global death by 2010.2 In the United States, deaths from chronic lower respiratory 
diseases, of which COPD comprises the bulk, rose to become the third leading cause of 
death in 2008.4 In international comparisons, the mortality rate from COPD in the United 
States ranks high;5 therefore, understanding trends in COPD mortality is of utmost 
importance in formulating appropriate public health initiatives to ease the burden of this 
disease.
A recent report showed that age-adjusted mortality rates from COPD declined substantially 
from 1994 to 2010 in the European Community and in most countries.6 In comparison, the 
age-adjusted mortality rate from COPD in the United States generally rose from 1970 to 
2000 and then leveled off afterwards.7,8,9,10,11 To provide more detailed insights into the 
trend of the COPD mortality rate in the United States, the author examined national vital 
statistics data from 1968 to 2011 among adults aged ≥25 years.
Methods
Mortality data for adults aged 25 years or older were obtained from the Wide-ranging 
Online Data for Epidemiologic Research (WONDER) system developed and maintained by 
the Centers for Disease Control and Prevention.12 WONDER is an interactive web-based 
tool built with data from the National Vital Statistics System. Institutional Review Board 
approval was not required for this analysis of publically available data.
Deaths from COPD as the underlying cause of death were tabulated by using Eighth 
Revision of the International Classification of Diseases, Adapted for Use in the United 
States (ICDA-8) codes 490, 491, 492, and 519.3 (introduced in 1969) from 1968 to 1978, 
ICD-9 codes 490-492, 496 from 1979 to 1998, and ICD-10 codes J40-J44 from 1999 to 
2011. Population estimates produced by the Bureau of the Census in collaboration with the 
National Center for Health Statistics provided the denominators needed to calculate rates for 
each year. Age-adjustment was done using the direct method to the projected year 2000 US 
population. Age-adjusted rates using the age-groups shown below were generated for all 
adults aged ≥25 years, men, women, whites, African Americans, other race, gender by race 
groups, and age-specific rates were generated for the age groups 25–34, 35–44, 45–54, 55–
64, 65–74, 75–84, and ≥85 years.
Trends were analyzed using the Joinpoint (version 4.1.0) statistical program.13 This program 
identifies years when changes in the estimated annual percentage change (APC) in the 
mortality rate occurs by performing a Monte Carlo permutation test and proceeds to fit the 
simplest model with the fewest number of trend segments.14 The APC is calculated as APCi 
= [(Exp(bi) − 1)] × 100 where bi represents the slope of the period segment.15 As many as 5 
trend segments were allowed, and mortality rates were log-transformed. Differences in the 
slopes for adjacent trend segments were tested with t-tests.
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Overall, the age-adjusted mortality rate from COPD rose steadily from 29.4 per 100,000 
population in 1968 to 67.0 per 100,000 population in 1999 and then declined gradually to 
63.7 per 100,000 population in 2011 (Figure 1). The APC was 3.0% (95% CI: 2.7, 3.4) from 
1968 to 1987, 1.9% (95% CI: 1.4, 2.3) from 1987 to 2000, and −0.2% (95% CI: −0.6, 0.2) 
from 2000 to 2011 (Table 1). Thus, there was a deceleration in the age-adjusted mortality 
rate during successive periods. The slope for the two latter periods was significantly 
different from that of each preceding period. The mortality rate in 2011 (63.7 per 100,000 
population) was 5.0% lower than in 1999 (67.0 per 100,000 population).
Among men, the mortality rate from 1968 (56.4 per 100,000 population) to its peak in 1999 
(88.2 per 100,000 population) increased by about 60% and then decreased by 16.6% by 
2011 (73.5 per 100,000 population). The APC increased by 2.1% per years (95% CI: 1.8, 
2.4) from 1968 to 1985, changed little from 1985 to 1999 (0.1%, 95% CI: −0.2, 0.5), and 
decreased by −1.1% per years (95% CI: −1.4, −0.7) from 1999 to 2011 (Table 1). Among 
women, the age-adjusted mortality rate from 1968 (9.4 per 100,000 population) to its peak in 
2008 (59.1 per 100,000 population) increased by 530%. The APC decreased progressively in 
three successive periods: 7.1% (95% CI: 6.6, 7.5) from 1968 to 1988, 3.7% (95% CI: 3.2, 
4.3) from 1988 to 2000, and 0.4% (95% CI: 0.0, 0.9) from 2000 to 2011 (Table 1). 
Nevertheless, the APC in the latter period was positive and significant indicating that rates 
may still be rising among women. Rates in 1968 were approximately 6-fold higher in men 
than women, but the gap between men and women narrowed substantially so that by 2008 
the rate in men was only 1.3 times higher in men than women. The gender difference in rates 
reached a maximum of 54.4 per 100,000 population in 1976 and declined to 16.2 per 
100,000 population in 2011.
The age-adjusted rates for African Americans, whites, and adults of a race other than 
African American and white peaked in 1999 and were from 3.1% to 19.2% lower in 2011 
(Figure 2). Only among adults of a race other than African American or white did the APC 
decrease significantly from 1999–2011 (Table 1). The ratio of rates in whites to African 
Americans ranged between 1.5 and 1.8 and did not vary greatly during the study period, but 
the absolute difference in age-adjusted rates increased from 12.8 per 100,000 population in 
1970 to 27.3 per 100,000 population in 2008.
The age-adjusted mortality rates among white and African American men peaked in 1999 
and the rate of men of a race other than African American and white peaked in 2000. The 
mortality rates among white and African American women peaked in 2008, and the rate of 
women of a race other than African American and white peaked in 1999. The age-adjusted 
rates in white adults were substantially higher than those in African American adults and 
adults of a race other than African American and white (Figure 3). From 1999 to 2011, 
significant decreases in the APC were present among African American men, white men, 
and men of races other than white and African American (Table 1). In contrast, significant 
increases in the APC were noted among African American and white women. Among 
women, the white/African American ratio fluctuated between 1.7 and 2.3 with no clear 
trend. In contrast, the white/African American ratio among men tended to decrease from 1.8 
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in 1968 to about 1.2–1.3 in 1988 and beyond. The absolute difference between white and 
African American women increased from 4.4 per 100,000 population in 1968 to 31.1 per 
100,000 population in 2003, remaining high in subsequent years. In contrast, the absolute 
difference in rates between white and African American men narrowed from a high of 31.4 
per 100,000 population in 1975 to 15.6 per 100,000 population in 2005.
The age-specific rates showed a powerful gradient: the rate among adults aged ≥85 years 
was as much as approximately 6000-fold higher than adults aged 25–34 years and as much 
as 700-fold higher than adults aged 35–44 years (Figure 4, 5). The age-specific rates among 
adults aged 25–34 years, 35–44 years, 45–54 years, and 55–64 years were at their peaks in 
1969, 1969, 1971, and 1989, respectively, and at their lows during 1992, 1990, 1998, and 
2006, respectively. In the three youngest age groups, rates in 2011 were approximately 50% 
higher than the ones at their nadir. In the older age groups, the pattern was reversed: the 
lowest rates among adults aged 65–74 years, 75–84 years, and ≥85 years occurred during 
1968, 1968, and 1970, respectively, whereas the highest rates occurred during 1999, 2008, 
and 2008, respectively. The APC decreased significantly among adults aged 35–44 years 
since 2002, 55–64 years since 1989, and 65–74 years since 1999, but increased among those 
aged 25–34 years since 1983 and 45–54 years since 1998, and ≥85 years since 2001 (Table 
1).
Discussion
The findings from this study document changes in the mortality rate from COPD among US 
adults aged ≥25 years over a 44-year period and illustrate several points. First, rates are no 
longer rising in all adults. Since 1999, the APC has decreased significantly in men but is still 
rising, albeit at a much slower rate, in women. Two, rates in men continue to exceed those in 
women, but there has been a substantial narrowing of the gender gap. Third, rates in whites 
are greater than those in African Americans, and the difference in absolute rates between the 
two groups has widened driven by the divergence in rates among white and African 
American women. Fourth, the patterns of the trends differed markedly among the age 
groups.
Several recent publications have described changes in mortality from COPD in Europe, 
Australia, and Japan.5,6,16 In the European Union, the age-adjusted rates of mortality from 
COPD among adults aged ≥40 years from 1994 to 2010 declined continuously in men with 
relatively stable rates in women.6 However, the rate aggregated over 27 countries masked 
considerable variation among countries. The pattern in the United States was similar to that 
in Sweden where the rate in men peaked around 2000 before declining, and the rate in 
women continued to increase but at a slower pace during the tail end of the study period. In 
Australia, the age-adjusted rate in men aged ≥55 years increased sharply from 1965 to 1970 
and thereafter started a continuous decline that was particularly steep from 1988 to 2006.5 In 
women, however, the age-adjusted rate increased from 1965 to 1997 before starting a 
moderate decline. In Japan, the age-adjusted rate of mortality from COPD in adults aged 
≥40 years decreased from 71.3 per 100,000 population in 1950 to 19.7 per 100,000 
population in 2004 in men and from 41.7 to 4.3 per 100,000 population in women.16
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The current analysis shows that the mortality rate among men continues to exceed that in 
women. A previous analysis of mortality data from 1968 to 1999 in the United States 
reported a narrowing of the gender gap in mortality rates.8 The current analysis shows a 
further narrowing of this gap through 2011. National data show interesting gender 
differences in COPD statistics. Men have higher mortality rates and a higher prevalence of 
obstructive lung function than women, yet women are more likely to report having COPD in 
surveys.7,11,17,18
Despite substantial declines in the prevalence of smoking in the United States since 1965,19 
mortality from COPD has remained intractably high reflecting the lingering burden of 
tobacco use from decades past and the long lag period between tobacco use and its effect on 
mortality. The declining rate in men since 1999 is a welcome development, and given the 
continuing decline in tobacco use, further declines in the mortality rate in men can be 
anticipated. There is also a suggestion in the data that the increase in COPD mortality in 
women may be leveling off, but additional data are required to bear this contention out. 
Furthermore, the age-specific rates in adults younger than 65 years suggest that future 
declines in the rate of COPD mortality are likely. However, it should be noted that the year 
when the rates reached a minimum generally occurred during the 1990s (2006 for adults 
aged 55–64 years), and the rates among adults aged 25–34 years and 45–54 years have 
increased significantly since reaching their nadirs. Thus, the mortality rate in these age 
cohorts should continue to be carefully monitored. Reasons for these apparent increases are 
unclear as the prevalence of current smokers has been declining in all age groups as well as 
in the 1960 and 1980 birth cohorts although the downturn for the latter cohort started only 
about a decade ago.20
Because tobacco use is the single biggest contributor to the development of COPD,20 
continued public health efforts to prevent the initiation of tobacco use and smoking cessation 
among those who continue to smoke are needed to further lower the prevalence of tobacco 
use. Although the prevalence of cigarette smoking among US adults was 19.0% in 2011, 
considerable interstate variation in the prevalence in 2012 existed with a range of 10.6% to 
28.6%.21 These estimates suggest that substantial advances in reducing the prevalence of 
current smoking are feasible.
Several limitations of the present analysis merit consideration. First, the validity of COPD 
codes on death certificates is unknown. A few studies in the United States suggest that death 
from COPD is underreported on death certificates.22,23 Second, the study period covered 
several ICD transitions raising the prospect of abrupt artificial changes in mortality rates. 
The comparability ratio for ICD codes 490-491 in ICD8 and ICD9 was 0.9383, whereas the 
comparability ratio for code 492 was 0.9770.24 The comparability ratio for the category 
chronic lower respiratory disease for the transition from ICD9 to ICD10 was 1.0478.25 
Third, this study, like many other mortality studies, examined only COPD as the underlying 
cause of death. Studies using multiple cause of death provide a fuller picture of the burden 
associated with COPD. Fourth, separating out persons of Hispanic heritage was not possible 
for the entire study period.
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In conclusion, the age-adjusted mortality rate from COPD peaked in 1999 and has decreased 
nonsignificantly since then reflecting a significant decline in men and a significant increase 
among women. Men continue to die at higher rates than women although the gap has 
narrowed, and whites die at higher rates than African Americans with a widening mortality 
gap. Although it continues to be asserted that mortality from COPD has been rising, the 
findings from the present study make clear that the mortality rate from COPD among US 
adults has stopped rising and has even started to decline in some demographic groups.
Abbreviations
APC annual percentage change
COPD chronic obstructive pulmonary disease
ICD International Classification of Diseases
WONDER Wide-ranging Online Data for Epidemiologic Research
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Age-adjusted mortality rate from chronic obstructive pulmonary disease among US adults 
aged ≥25 years, United States 1968–2011
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Age-adjusted mortality rate from chronic obstructive pulmonary disease among US adults 
aged ≥25 years, by race, United States 1968–2011
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Age-adjusted mortality rate from chronic obstructive pulmonary disease among US adults 
aged ≥25 years, by race and gender, United States 1968–2011
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Age-specific mortality rate from chronic obstructive pulmonary disease among US adults 
aged ≥25 years, United States 1968–2011
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Age-specific mortality rate from chronic obstructive pulmonary disease among US adults 
aged ≥25 years graphed on a log-scale, United States 1968–2011
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